Supporting Oncology Practices with Specialized CPA and Practice Management Expertise
Oncology practices face complex financial, compliance, and operational pressures—balancing high-cost treatments, evolving reimbursement models, and increased regulatory oversight. Reed Tinsley, CPA, CFP, works directly with oncologists and cancer care centers across Texas and the U.S. to provide specialized accounting, tax, and advisory support. With over 30 years of experience in healthcare finance, Reed helps oncology practices strengthen profitability, streamline operations, and prepare for the future.
How Reed Tinsley Helps Oncology Practices Thrive
Reed delivers tailored financial and advisory solutions built for the realities of oncology. His accounting services include financial statement preparation, independent reviews, overhead analysis, and revenue cycle support—especially critical for infusion billing and drug reimbursements. His tax services prioritize strategic planning, buy-in/buy-out structuring, and merger-related tax analysis to help practices minimize liability and build long-term value. Reed’s valuation and brokerage expertise supports oncology physicians looking to transition, merge, or sell their practice, with guidance on fair market value, goodwill, and compliance with Stark and anti-kickback laws. For practices in distress or under legal scrutiny, he offers litigation support and medical practice receivership. Reed also brings Certified Financial Planner™ insight to personal financial planning for oncologists—offering retirement planning, wealth protection, and customized strategies for practice owners.Frequently Asked Questions
Oncology practices often face complex tax scenarios due to high-cost drug inventory, multiple revenue streams, and varying payer contracts. Reed applies proactive tax planning strategies that account for drug purchase deductions, entity structuring, retirement contributions, and capital investment planning. His guidance helps reduce tax liability, increase after-tax income, and avoid year-end surprises. He also advises on tax implications related to practice mergers, ownership transitions, and infusion billing revenue.
Yes. Oncology practices frequently struggle with denied claims, delayed reimbursements, and improper coding—especially for chemotherapy and biologics. Reed helps evaluate billing workflows, ensures payer eligibility verification, and analyzes denial trends. He can recommend improvements that lead to faster collections, reduced write-offs, and improved margins across all service lines, including lab and infusion services.
Reed primarily uses the income approach when valuing oncology practices, which focuses on projected cash flow and adjusted physician compensation. This method accounts for infusion drug costs, payer mix, and reimbursement volatility, as well as goodwill and operational efficiency. Reed also considers compliance factors such as Stark Law and Anti-Kickback Statutes when structuring deals, ensuring a fair and defensible valuation.
Reed offers full-service medical practice brokerage, including market analysis, buyer matching, and deal structuring for oncology practices. He conducts due diligence, helps draft agreements, and advises on financial and legal risks. Whether selling to a hospital system, PE-backed group, or individual physician, Reed ensures a smooth, compliant transition that maximizes the seller’s return.
Absolutely. Oncology specialists often face long hours, emotional burnout, and delayed wealth accumulation due to educational debt and late career start. Reed’s personal financial planning oversight includes retirement planning, risk management, investment strategies, and succession planning—designed specifically for physician-owners. He helps oncologists align their personal and professional financial goals with a long-term, tax-efficient strategy.
Contact Reed Today